Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA Safety Alert For Hydroxychloroquine Is Latest Turn In Drug's Strange Journey
Apr 27 2020
•
By
Derrick Gingery
The US FDA said the EUA allowing hydroxychloroquine use for coronavirus was based on limited evidence, which is why only hospitalized patients should receive it. • Source: Shutterstock
More from Drug Safety
More from Pink Sheet